Nifty
Sensex
:
:
24252.00
77540.83
20.15 (0.08%)
3.11 (0.00%)

Pharmaceuticals & Drugs - API

Rating :
80/99

BSE: 532482 | NSE: GRANULES

858.15
21-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  843.6
  •  864.8
  •  843.6
  •  841.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  406173
  •  347782129.85
  •  910
  •  456.3

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 21,272.13
  • 32.12
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 21,661.20
  • 0.20%
  • 4.34

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.02%
  • 6.31%
  • 17.84%
  • FII
  • DII
  • Others
  • 17.5%
  • 12.26%
  • 8.07%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.29
  • 7.34
  • 5.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.77
  • 10.43
  • 6.72

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.72
  • 7.59
  • 13.65

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.91
  • 23.73
  • 26.68

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.15
  • 3.33
  • 3.58

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.73
  • 12.49
  • 14.17

Earnings Forecasts:

(Updated: 22-08-2026)
Description
2026
2027
2028
2029
Adj EPS
76
6
26.83
23.26
P/E Ratio
11.29
143.03
31.98
36.89
Revenue
27.57
22.07
18.32
5293.22
EBITDA
6205.9
7090.79
8185.9
1145
Net Income
1411.43
1651.9
1986.42
578.22
ROA
775.73
961.31
1183.7
-
P/B Ratio
1.84
-1.33
-0.44
4.62
ROE
3.59
2.93
2.53
13.9
FCFF
13.38
13.99
14.55
-191.01
FCFF Yield
176.75
442.07
971.6
-0.91
Net Debt
0.84
2.1
4.62
576.93
BVPS
465.87
-645.8
-1944.25
185.8

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
1,476.77
1,210.11
22.04%
1,470.61
1,197.43
22.81%
1,387.94
1,137.70
22.00%
1,296.99
966.62
34.18%
Expenses
1,137.87
963.39
18.11%
1,118.50
945.07
18.35%
1,079.84
907.40
19.00%
1,018.76
763.30
33.47%
EBITDA
338.91
246.72
37.37%
352.10
252.36
39.52%
308.10
230.29
33.79%
278.23
203.32
36.84%
EBIDTM
22.95%
20.39%
23.94%
21.07%
22.20%
20.24%
21.45%
21.03%
Other Income
2.27
16.34
-86.11%
8.77
1.92
356.77%
-3.64
5.68
-
-1.15
3.25
-
Interest
21.12
23.78
-11.19%
32.69
23.98
36.32%
28.69
26.57
7.98%
29.19
25.67
13.71%
Depreciation
79.65
68.85
15.69%
81.75
63.50
28.74%
73.53
56.61
29.89%
72.02
52.52
37.13%
PBT
240.40
144.53
66.33%
262.36
197.55
32.81%
202.23
152.79
32.36%
175.87
128.38
36.99%
Tax
60.44
31.89
89.53%
60.79
45.52
33.55%
52.02
35.19
47.83%
45.26
31.15
45.30%
PAT
179.96
112.64
59.77%
201.57
152.03
32.59%
150.21
117.60
27.73%
130.61
97.23
34.33%
PATM
12.19%
9.31%
13.71%
12.70%
10.82%
10.34%
10.07%
10.06%
EPS
7.26
4.64
56.47%
8.13
6.27
29.67%
6.19
4.85
27.63%
5.38
4.01
34.16%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
5,632.31
5,365.64
4,481.61
4,506.37
4,511.92
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
Net Sales Growth
24.83%
19.73%
-0.55%
-0.12%
19.84%
16.29%
24.59%
14.02%
35.29%
19.43%
 
Cost Of Goods Sold
1,958.45
1,875.70
1,725.70
2,021.25
2,307.28
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
Gross Profit
3,673.86
3,489.94
2,755.91
2,485.12
2,204.63
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
GP Margin
65.23%
65.04%
61.49%
55.15%
48.86%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
Total Expenditure
4,354.97
4,180.50
3,536.37
3,650.39
3,598.60
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
Power & Fuel Cost
-
128.87
100.74
100.64
95.69
74.66
68.85
59.74
57.67
48.22
38.67
% Of Sales
-
2.40%
2.25%
2.23%
2.12%
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
Employee Cost
-
849.14
619.66
550.24
420.35
366.44
324.29
259.04
209.82
165.21
140.19
% Of Sales
-
15.83%
13.83%
12.21%
9.32%
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
Manufacturing Exp.
-
593.97
469.82
408.01
273.93
298.74
228.39
177.94
157.62
120.84
86.23
% Of Sales
-
11.07%
10.48%
9.05%
6.07%
7.93%
7.05%
6.85%
6.92%
7.17%
6.11%
General & Admin Exp.
-
339.66
279.35
211.99
187.96
134.41
172.28
125.63
99.96
83.05
70.02
% Of Sales
-
6.33%
6.23%
4.70%
4.17%
3.57%
5.32%
4.83%
4.39%
4.93%
4.96%
Selling & Distn. Exp.
-
333.41
297.79
290.63
280.00
247.45
159.80
112.17
91.84
83.08
81.37
% Of Sales
-
6.21%
6.64%
6.45%
6.21%
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
Miscellaneous Exp.
-
59.75
43.32
67.62
33.38
37.96
37.42
57.88
22.69
9.49
81.37
% Of Sales
-
1.11%
0.97%
1.50%
0.74%
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
EBITDA
1,277.34
1,185.14
945.24
855.98
913.32
721.62
855.23
525.32
384.04
278.42
298.84
EBITDA Margin
22.68%
22.09%
21.09%
18.99%
20.24%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
Other Income
6.25
20.33
12.92
4.40
14.29
18.22
26.88
36.56
26.68
10.84
9.93
Interest
111.69
114.35
103.24
105.82
55.93
23.21
26.28
27.02
28.46
33.06
32.26
Depreciation
306.95
296.14
225.50
207.33
184.49
158.63
151.46
136.95
105.48
76.20
71.51
PBT
880.86
794.98
629.42
547.23
687.17
558.00
704.36
397.90
276.78
180.00
204.99
Tax
218.51
189.96
158.65
141.92
170.58
145.24
154.91
115.73
89.11
63.40
65.20
Tax Rate
24.81%
24.20%
24.03%
25.93%
24.82%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
PAT
662.35
595.02
501.52
405.31
516.60
412.76
549.46
335.40
236.41
132.59
164.52
PAT before Minority Interest
662.35
595.02
501.52
405.31
516.60
412.76
549.46
335.40
236.41
132.59
164.52
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.76%
11.09%
11.19%
8.99%
11.45%
10.96%
16.97%
12.91%
10.37%
7.87%
11.66%
PAT Growth
38.13%
18.64%
23.74%
-21.54%
25.16%
-24.88%
63.82%
41.87%
78.30%
-19.41%
 
EPS
26.73
24.01
20.24
16.36
20.85
16.66
22.17
13.54
9.54
5.35
6.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
5,084.99
3,715.58
3,225.54
2,834.91
2,586.54
2,173.27
1,843.72
1,529.47
1,304.18
903.60
Share Capital
24.78
24.25
24.24
24.20
24.80
24.77
25.42
25.42
25.38
22.87
Total Reserves
4,694.59
3,677.62
3,183.00
2,792.68
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
Non-Current Liabilities
479.07
465.99
176.04
254.73
282.83
366.30
485.98
552.63
488.19
187.99
Secured Loans
297.15
311.51
68.97
148.64
233.70
333.81
414.83
478.78
433.13
123.90
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
6.69
0.00
0.00
0.34
Long Term Provisions
47.78
31.76
37.88
29.26
28.31
24.84
21.50
12.58
7.70
7.25
Current Liabilities
2,092.03
2,003.16
2,082.29
1,813.50
1,641.60
1,173.10
893.40
896.48
877.91
787.13
Trade Payables
672.80
726.07
749.53
782.13
638.61
541.05
356.88
323.48
274.35
215.98
Other Current Liabilities
336.07
304.61
261.08
193.19
200.85
194.25
153.16
113.60
69.84
93.43
Short Term Borrowings
1,025.34
922.56
1,054.24
810.88
765.58
409.27
371.69
454.21
525.10
473.83
Short Term Provisions
57.81
49.92
17.45
27.31
36.56
28.53
11.66
5.20
8.62
3.90
Total Liabilities
7,656.09
6,184.73
5,483.87
4,903.14
4,511.53
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
Net Block
3,250.12
2,426.47
2,095.62
1,910.92
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
Gross Block
4,987.94
3,882.08
3,351.81
2,981.22
2,461.77
2,145.15
1,875.23
1,472.94
1,199.63
983.66
Accumulated Depreciation
1,737.82
1,455.61
1,256.19
1,070.30
920.59
813.15
671.26
528.69
422.90
339.32
Non Current Assets
3,888.45
3,069.25
2,578.83
2,328.99
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
Capital Work in Progress
409.54
440.19
271.70
239.39
356.23
239.08
294.20
495.95
514.52
267.43
Non Current Investment
0.84
22.04
21.52
21.21
19.67
18.99
19.34
210.42
156.56
108.23
Long Term Loans & Adv.
226.32
179.51
190.00
157.47
89.47
125.61
76.89
45.72
35.91
30.56
Other Non Current Assets
1.64
1.04
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
3,767.65
3,115.48
2,905.05
2,574.15
2,504.99
1,997.00
1,518.85
1,282.24
1,186.57
828.16
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,673.03
1,342.82
1,300.55
1,149.41
978.55
782.18
438.43
384.21
279.95
269.18
Sundry Debtors
909.37
942.22
985.83
948.54
924.95
765.42
662.04
673.54
628.25
417.70
Cash & Bank
949.06
596.38
386.38
312.79
409.46
271.04
283.94
89.04
115.64
49.80
Other Current Assets
236.19
53.91
46.28
49.22
192.02
178.35
134.43
135.45
162.73
91.49
Short Term Loans & Adv.
162.95
180.15
186.00
114.19
130.35
127.61
91.83
98.46
114.09
51.66
Net Current Assets
1,675.62
1,112.32
822.75
760.65
863.38
823.90
625.45
385.76
308.65
41.03
Total Assets
7,656.10
6,184.73
5,483.88
4,903.14
4,511.53
3,712.68
3,113.26
2,978.58
2,670.28
1,878.71

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
793.25
866.57
439.41
738.75
332.06
432.48
476.19
262.24
-0.65
188.24
PBT
784.98
660.17
547.23
687.17
558.00
704.36
425.64
276.78
180.00
204.99
Adjustment
390.12
344.13
328.80
237.69
176.29
194.43
156.88
149.85
107.45
95.14
Changes in Working Capital
-141.66
6.02
-246.32
-10.31
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
Cash after chg. in Working capital
1,033.45
1,010.32
629.71
914.55
477.11
623.84
595.27
350.69
57.42
247.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-240.20
-143.75
-190.30
-175.80
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-773.21
-691.29
-360.16
-191.36
-380.12
-277.13
-160.63
-269.82
-462.31
-326.09
Net Fixed Assets
-156.56
-254.98
-101.04
-104.53
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
Net Investments
-748.29
-340.13
-264.87
-80.00
-5.00
-146.14
61.07
-431.34
-0.01
13.84
Others
131.64
-96.18
5.75
-6.83
-72.51
73.43
-97.13
337.88
-180.29
-90.07
Cash from Financing Activity
379.29
-92.51
7.66
-440.29
190.00
-299.31
-212.85
-17.43
528.62
55.87
Net Cash Inflow / Outflow
399.33
82.77
86.92
107.10
141.94
-143.97
102.70
-25.01
65.66
-81.98
Opening Cash & Equivalents
466.11
381.10
291.56
184.71
41.84
185.93
83.02
108.03
42.37
124.35
Closing Cash & Equivalent
880.24
466.11
381.10
291.56
184.71
41.84
185.93
83.02
108.03
42.37

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
190.45
152.63
132.33
116.38
103.62
86.85
71.80
59.73
51.17
39.40
ROA
8.60%
8.60%
7.80%
10.97%
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
ROE
14.13%
14.52%
13.46%
19.18%
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
ROCE
15.74%
16.16%
15.66%
19.63%
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
Fixed Asset Turnover
2.26
2.06
2.07
1.66
1.63
1.97
1.75
1.78
1.55
1.59
Receivable days
33.72
47.23
53.89
75.78
81.94
65.94
83.34
100.03
112.83
100.84
Inventory Days
54.92
64.75
68.26
86.07
85.35
56.39
51.34
51.03
59.23
66.49
Payable days
136.11
156.05
138.29
112.38
114.29
117.79
58.20
54.96
62.37
64.87
Cash Conversion Cycle
-47.47
-44.08
-16.14
49.48
52.99
4.54
76.48
96.10
109.70
102.46
Total Debt/Equity
0.28
0.35
0.38
0.38
0.43
0.39
0.49
0.65
0.75
0.73
Interest Cover
7.86
7.39
6.17
13.29
25.04
27.80
16.75
10.72
6.44
7.36

News Update:


  • Granules India - Quarterly Results
    22nd Jul 2026, 00:00 AM

    Read More
  • Granules India reports 60% jump in Q1 consolidated net profit
    21st Jul 2026, 14:38 PM

    The total consolidated income of the company has increased by 20.60% at Rs 1,479.04 crore for Q1FY27

    Read More
  • Granules India secures sole FTF ANDA status for Sodium Oxybate
    6th Jul 2026, 09:57 AM

    It is the generic equivalent of LUMRYZ extended-release oral suspension

    Read More
  • Granules India’s arm receives Establishment Inspection Report from USFDA
    3rd Jun 2026, 14:12 PM

    The inspection was conducted from March 30 to April 3, 2026, during which four Form 483 observations were issued

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.